StonvexLoading…
StonvexStonvexStonvexCore line items from SSTI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $104.13M | $102.03M | $92.72M | $81.00M |
Operating Income | $-8.73M | $-7.86M | $-1.24M | $7.75M |
Net Income | $-9.42M | $-9.18M | $-2.72M | $6.38M |
EPS (Diluted) | $-0.74 | $-0.72 | $-0.22 | $0.52 |
Total Assets | $135.75M | $136.79M | $138.71M | $122.75M |
Total Liabilities | $63.58M | $64.39M | $63.95M | $61.80M |
Cash & Equivalents | $15.80M | $13.18M | $5.70M | $10.48M |
Free Cash Flow OCF − CapEx | $4.85M | $15.89M | $5.90M | $1.27M |
Shares Outstanding | 12.83M | 12.63M | 12.76M | 12.24M |